Intertek Group plc has acquired Suplilab, enhancing its position in the rapidly growing Risk-based Quality Assurance market in Costa Rica's food safety and medical device testing sectors.

Target Information

Intertek Group plc has acquired Suplilab, a premier provider of food safety and medical device testing services based in San José, Costa Rica. Suplilab is recognized for its leading technical expertise in microbiology, water, and chemistry testing, and has established a strong position in rapid growth sectors characterized by high profit margins. The company employs 38 skilled professionals and reported revenues of £3.1 million in 2024.

This acquisition marks an important milestone for Intertek, as it allows the Group to tap into Central America's burgeoning demand for Risk-based Quality Assurance solutions, particularly in food safety and medical devices. The region's economic growth significantly enhances opportunities for quality assurance services that cater to the rising consumer demand for safer and sustainable food products.

Industry Overview

The Costa Rican economy is experiencing rapid growth, positioning the country as a key player in the Central American market for Risk-based Quality Assurance services. The increa

View Source

Similar Deals

Medibank Better Medical

2026

Other Hospitals, Clinics & Primary Care Services Australia
Abbott Exact Sciences

2026

Other In-Vivo Diagnostic & Testing Substances United States of America
ルネサンス マイリハ

2026

Other Residential & Long-Term Care Japan
Edwards Lifesciences JenaValve Technology

2026

Other Medical Devices & Implants United States of America

Intertek Group plc

invested in

Suplilab

in 2025

in a Other deal

Disclosed details

Revenue: $4M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert